Under the terms of the agreement, Pfizer is expected to pay an upfront total of $30 million in early 2026 to Novavax, while ...

Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.

Novavax (NASDAQ:NVAX) shares climbed about 5% on Tuesday after the biotech group disclosed a non-exclusive licensing ...

LAS VEGAS, NV, UNITED STATES, January 15, 2026 /EINPresswire.com/ -- The curtain rose on the International Consumer ...

The agreement allows Pfizer to utilize Novavax’s Matrix-M adjuvant in up to two disease areas with its products. Under the terms of the deal, Novavax will receive an upfront payment of $30 million and ...

The new Audi Q3 sets new standards in headlight development with lighting technology from ZKW. The technological highlights of the compact SUV include the digital Matrix LED headlights, which are ...

Chinese robotics startup Matrix Robotics on Monday unveiled its latest humanoid robot, MATRIX-3, a physically intelligent ...

What Happened? Shares of vaccine biotechnology company Novavax (NASDAQ:NVAX) jumped 19.7% in the afternoon session after the ...

Initiative focuses on the design, simulation and testing of a carbon fiber yacht mast, seeking to replace traditional ...

MarketNsight, a leading housing data research and consulting firm, announced the appointment of Eugene James as its new ...

DOVER, DE, UNITED STATES, January 15, 2026 /EINPresswire.com/ -- The safety of parenteral medicines and medical devices ...